Kevin Maloney PhD

Kevin Maloney is Sr. Director of Biologics Drug Product Development at Biogen in Cambridge, MA, with responsibility for parenteral formulation development and aseptic fill-finish development. Before Biogen, Kevin began his biopharmaceuticals career with Amgen. A guiding CMC development theme Kevin has experienced over a nearly 3-decade career is the concept of end-to-end development. A robust combination product control strategy considers interconnected parameters between the drug substance, the drug product, and the device during the development process. Kevin earned degrees in Chemistry from Worcester Polytechnic Institute and the Oregon Graduate Institute of Science and Technology and pursued post-doctoral studies at Caltech.